Prestige Consumer Healthcare, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US74112D1019
USD
60.06
-0.22 (-0.36%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
1,137.76
1,125.36
1,127.72
1,086.81
943.37
963.01
975.78
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,137.76
1,125.36
1,127.72
1,086.81
943.37
963.01
975.78
Raw Material Cost
524.59
523.46
527.51
491.03
419.83
426.35
447.05
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
47.63
67.16
69.16
61.86
77.57
96.57
105.30
Selling and Distribution Expenses
263.93
259.47
252.41
265.86
226.13
236.31
228.55
Other Expenses
-4.76
-6.72
-6.92
-6.19
-7.76
-9.66
-10.53
Total Expenditure (Excl Depreciation)
788.52
782.93
779.92
756.89
645.96
662.65
675.60
Operating Profit (PBDIT) excl Other Income
349.20000000000005
342.40000000000003
347.8
329.90000000000003
297.4
300.4
300.2
Other Income
-4.95
0.76
-2.34
-3.48
-1.05
-1.28
1.02
Operating Profit (PBDIT)
374.46
373.86
384.40
365.24
333.60
336.85
332.98
Interest
47.63
67.16
69.16
61.86
77.57
96.57
105.30
Exceptional Items
-12.47
0.00
-370.22
-2.12
-14.67
-11.36
-233.96
Gross Profit (PBDT)
613.17
601.90
600.22
595.78
523.53
536.66
528.73
Depreciation
30.17
30.68
38.94
38.80
37.25
37.78
31.78
Profit Before Tax
284.19
276.02
-93.92
262.46
204.11
191.15
-38.05
Tax
69.58
66.69
-11.61
57.08
39.43
48.87
-2.25
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
214.60
209.34
-82.31
205.38
164.68
142.28
-35.80
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
214.60
209.34
-82.31
205.38
164.68
142.28
-35.80
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
214.60
209.34
-82.31
205.38
164.68
142.28
-35.80
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
1,834.90
1,655.08
1,447.08
1,577.61
1,358.30
1,170.97
1,095.83
Earnings per share (EPS)
4.29
4.17
-1.65
4.04
3.25
2.78
-0.69
Diluted Earnings per share
4.29
4.17
-1.65
4.04
3.25
2.78
-0.69
Operating Profit Margin (Excl OI)
30.7%
30.43%
30.84%
30.36%
31.53%
31.19%
30.76%
Gross Profit Margin
27.63%
27.25%
-4.88%
27.72%
25.58%
23.77%
-0.64%
PAT Margin
18.86%
18.6%
-7.3%
18.9%
17.46%
14.77%
-3.67%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 1.10% vs -0.20% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 2.53% vs 354.31% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 1.69% vs -3.52% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -29.17% vs -2.89% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Prestige Consumer Healthcare, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
1,137.76
0
1,137.76
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,137.76
0
1,137.76
Raw Material Cost
524.59
0
524.59
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
47.63
0
47.63
Selling and Distribution Expenses
263.93
0
263.93
Other Expenses
-4.76
0.00
-4.76
Total Expenditure (Excl Depreciation)
788.52
0
788.52
Operating Profit (PBDIT) excl Other Income
349.24
0.00
349.24
Other Income
-4.95
0
-4.95
Operating Profit (PBDIT)
374.46
0
374.46
Interest
47.63
0
47.63
Exceptional Items
-12.47
0
-12.47
Gross Profit (PBDT)
613.17
0
613.17
Depreciation
30.17
0
30.17
Profit Before Tax
284.19
0
284.19
Tax
69.58
0
69.58
Provisions and contingencies
0
0
0.00
Profit After Tax
214.60
0
214.60
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
214.60
0
214.60
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
214.60
0
214.60
Equity Capital
0
0
0.00
Face Value
0.01
0
0.00
Reserves
1,834.90
0
1,834.90
Earnings per share (EPS)
4.29
0
4.29
Diluted Earnings per share
4.29
0
4.29
Operating Profit Margin (Excl OI)
30.70%
0%
0.00
30.70%
Gross Profit Margin
27.63%
0%
0.00
27.63%
PAT Margin
18.86%
0%
0.00
18.86%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 113.78 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 1.10% vs -0.20% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 21.46 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 2.53% vs 354.31% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 37.94 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is 1.69% vs -3.52% in Mar 2024

Annual - Interest
Interest 4.76 Million
in Mar 2025

Figures in Million
stock-summary

YoY Growth in year ended Mar 2025 is -29.17% vs -2.89% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.70%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024